跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
Dolased Forte (paracetamol 450 mg, codeine phosphate hemihydrate 30 mg, doxylamine succinate 5 mg) tablets blister pack
Approved
STANDARD
Dolased Forte (paracetamol 450 mg, codeine phosphate hemihydrate 30 mg, doxylamine succinate 5 mg) tablets blister pack
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
be91399d4aa6e77e
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
be91399d4aa6e77e
Product Name
Dolased Forte (paracetamol 450 mg, codeine phosphate hemihydrate 30 mg, doxylamine succinate 5 mg) tablets blister pack
Artg Id
203987
Artg Name
Dolased Forte (paracetamol 450 mg, codeine phosphate hemihydrate 30 mg, doxylamine succinate 5 mg) tablets blister
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
2013-12-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/bd2bebb46bdb677b358864a930770fb4.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/8ba9b0095a476381b6b474760ab09cfd.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
be91399d4aa6e77e
Type
Standard
Back to TGA Approvals
Dolased Forte (paracetamol 450 mg, codeine phosphate hemihydrate 30 mg, doxylamine succinate 5 mg) tablets blister pack - TGA Drug Approval Details